Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by wildbird1on May 29, 2023 9:46am
640 Views
Post# 35468560

HG NMIBC & CIS HG NMIBC...?????

HG NMIBC & CIS HG NMIBC...?????In the last Swimmer Plot TLT said "Red Dot = HG NMIBC".
At the next AGM we should ask TLT to clarify if the red dot are true HG NMIBC or Non-Response patients.

If you google HG NMIBC & CIS HG NMIBC, you will realize that there is a huge difference between a HG NMIBC and a CIS HG NMIBC patient.
- A HG NMIBC patient is not in imminent danger of losing his(her) bladder, and can be treated with BCG.
-A CIS HG NMIBC patient is in imminent danger of losing his(her) bladder, and is untreatable( for now).

All TLT patients are CIS HG NMIBC, they are all in danger of losing their bladder.
Could it be possible that after TLT treatment these CIS HG NMIBC patients did reverse back to being simply a HG NMIBC patient(no CIS)?
A HG NMIBC patient is simply a patient that is not cured, but he is not in imminent danger of losing his bladder( unlike a CIS HG NMIBC patient).
Or could it be that the term HG NMIBC in the last Swimmer Plot is a typo error? It is the third Swimmer Plot were TLT use the term HG NMIBC(without CIS), there is a big chance that it is not a typo error.

In the last Swimmer Plot at 450 days...
25 patients are HG NMIBC( they still have their bladder) .
11 patients are CR.
  1 patient is  IR.
Total 37 patients.
Note: In the May 10,2023 PressRelease, TLT said" The goal of therapy in patients with BCG-Unresponsive NMIBC is to avoid cystectomy".

The reason TLT should clarify this situation is, if these patients are true HG NMIBC ( not Non Response patients) it does change the dynamic of a Big Pharma deal, a Big Pharma would have to pay very very big money for a treatment were 100% of patients treated still have their bladder at 450 days(and counting).






<< Previous
Bullboard Posts
Next >>